Completed NCT00904670
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Irvine Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 6 Years to 12 Years
Countries United States
Sponsor Pfizer
Condition ADHD Completed NCT04152629
This study is completed in Canada. It focuses on ADHD.
Multiple locations, including Calgary Why is this study shown? This study is directly about ADHD.
ADHD Drug Over 6 Years
Countries Canada
Sponsor Purdue Pharma, Canada
Condition ADHD Terminated NCT04507204
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Drug Over 12 Years
Countries United States
Sponsor Purdue Pharma LP
Condition ADHD Completed NCT02580890
This summary needs review. Please check the official study record and contact the research team for details.
In Porto Alegre Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 18 Years to 50 Years
Countries Brazil
Sponsor Hospital de Clinicas de Porto Alegre
Condition ADHD Completed NCT06854601
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Yekaterinburg Why is this study shown? This study is directly about ADHD.
ADHD, Anxiety Drug From 6 Years to 12 Years
Countries Russia
Sponsor Pharmasoft
Condition ADHD, Anxiety Completed NCT00444574
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries
Sponsor Noven Therapeutics
Condition ADHD Completed NCT03260205
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Drug From 4 Years to 5 Years
Countries United States
Sponsor Shire
Condition ADHD Completed NCT02604407
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Encino Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor Shire
Condition ADHD Completed NCT02466425
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 6 Years to 17 Years
Countries United States
Sponsor Shire
Condition ADHD Terminated NCT03325894
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Drug From 4 Years to 12 Years
Countries United States
Sponsor Shire
Condition ADHD Completed NCT03327402
This study is completed in the United States. It is testing SHP465 for ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 4 Years to 5 Years
Countries United States
Sponsor Shire
Condition ADHD Withdrawn NCT03546400
This study was withdrawn. It is testing Methylphenidate HCl ERCT for ADHD.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 48 Months to 69 Months
Countries
Sponsor Pfizer
Condition ADHD